Robert Keith Woods
CIK: 0001995131
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NGNE
Neurogene Inc.
Director
Discretionary Trading P&L
Holdings
About Woods Robert Keith
Woods Robert Keith (SEC CIK 0001995131) files insider reports with the SEC as Director of Neurogene Inc. (NGNE).
Signal8 holds 1 ownership filing by Woods Robert Keith, a Form 4, filed on Jun 13, 2025. Those filings report 1 transaction, the latest on Jun 12, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Woods Robert Keith's filings is in NEW YORK, NY.
Recent filings by Woods Robert Keith
- Jun 12, 2025: Grant or award of NGNE derivative securities (Form 4, code A).
Other insiders filing for Neurogene Inc. (NGNE)
- McMinn Rachel, Chief Executive Officer
- Cvijic Christine Mikail, President and CFO
- Woods Keith, Director
- Shafer Christina, Chief Commercial Officer
- Jordan Julie, Chief Medical Officer
- Cobb Stuart, Chief Scientific Officer